Starting a new chapter in formulation development.

Smart and digital.

amofor provides advanced in-silico formulation development services and cutting-edge software tools to optimize and streamline your formulation processes.

Faster development. Better formulations.

About Us

amofor, founded as a spinoff from TU Dortmund University in 2019, is dedicated to supporting formulation scientists in the industry by enhancing the discovery and development of amorphous solid dispersions and other enabling formulation. Our mission is to offer reliable, efficient, and cutting-edge solutions that empower scientists to achieve better formulations with greater confidence and precision.

By partnering with amofor, you are choosing a team committed to excellence and innovation in formulation development.

Why Choose Us

Academic Excellence

Leverage our strong academic background and extensive research expertise, rooted in our origins at TU Dortmund University.

Industry Trust

Benefit from our proven track record with key industry leaders who trust our solutions for their most challenging projects

Validated In-Silico Models

Our approach has been rigorously tested and validated through hundreds of experiments, providing reliable and predictive formulation guidance.

Quick Turnaround

Experience short turnaround times that accelerate your formulation development process without compromising quality.

Scientific Expertise

Rely on our robust scientific expertise, validated by hundreds of experiments and a strong publication record of over 200 papers.

Physics-based simulations enhance the precision of pharmaceutical drug formulation. This blog presents a proof-of-principle study conducted in collaboration between amofor and Boehringer Ingelheim. This project aimed to evaluate the feasibility of shifting from spray-drying to hot-melt extrusion (HME) in producing amorphous solid dispersions (ASDs), focusing on in vitro and in vivo performance comparisons. Traditionally, spray-drying…
Release profiles are at the heart of successful formulations. However, drug formulation scientists struggle with them. Weeks of trial-and-error experiments. Unpredictable outcomes. No mechanistic understanding. amofor is now changing this...
In the last five years, amofor has rapidly transformed from a German academic start-up to a highly innovative force revolutionizing drug formulation with physics-based in silico modeling. On this occasion, the two founders, Christian Lübbert and Gabriele Sadowski, shed some light on the origins and driving forces behind amofor. Who is behind this company ...

Ready to Take the Next Chapter? Contact Us Today!

Lets get in touch and start together this transformative approach to formulation development through advanced in-silico methods.